Published in Int J Oncol on February 01, 1994
Stress response protein (srp-27) determination in primary human breast carcinomas: clinical, histologic, and prognostic correlations. J Natl Cancer Inst (1991) 3.07
Acute and nonacute complications associated with interscalene block and shoulder surgery: a prospective study. Anesthesiology (2001) 2.61
Endoscopic papillary balloon dilation vs. sphincterotomy for removal of common bile duct stones: a prospective randomized pilot study. Endoscopy (2001) 2.07
Comprehensive microRNA expression profiling of the hematopoietic hierarchy. Proc Natl Acad Sci U S A (2010) 1.67
The relationship between juxtapapillary duodenal diverticula and disorders of the biliopancreatic system: analysis of 350 patients. Gastrointest Endosc (2001) 1.63
Long-term results (7 to 10 years) of endoscopic papillotomy for choledocholithiasis. Multivariate analysis of prognostic factors for the recurrence of biliary symptoms. Gastrointest Endosc (1998) 1.60
Presentation and physical evaluation of RadioVisioGraphy. Oral Surg Oral Med Oral Pathol (1989) 1.58
Improved tumor staging by diagnostic laparoscopy. Z Gastroenterol (1999) 1.58
Immunogenicity of two accelerated hepatitis B vaccination protocols in liver transplant candidates. Eur J Gastroenterol Hepatol (2001) 1.48
Pancreatic endoscopic sphincterotomy in patients with chronic pancreatitis: a single-center experience in 171 consecutive patients. Endoscopy (2002) 1.47
Long-term follow-up of patients with iron deficiency anemia after a close endoscopic examination of the upper and lower gastrointestinal tract. Z Gastroenterol (2000) 1.41
Efficacy of intraoral topical anesthetics in children. J Dent (2005) 1.40
The HER2 (c-erbB-2) oncogene is frequently amplified in in situ carcinomas of the breast. Oncogene (1992) 1.34
A new HF current generator with automatically controlled system (Endocut mode) for endoscopic sphincterotomy--preliminary experience. Endoscopy (1998) 1.30
Transjugular intrahepatic portosystemic stent shunt versus sclerotherapy plus propranolol for variceal rebleeding. Gastroenterology (1997) 1.20
Markers of tumor angiogenesis and proteolysis independently define high- and low-risk subsets of node-negative breast cancer patients. J Clin Oncol (1998) 1.19
Psychological distress among male patients and male spouses: what do oncologists need to know? Ann Oncol (2009) 1.19
A role for both Ets and C/EBP transcription factors and mRNA stabilization in the MAPK-dependent increase in p21 (Cip-1/WAF1/mda6) protein levels in primary hepatocytes. Mol Biol Cell (2000) 1.16
Estrogen-induced post-transcriptional modulation of c-myc proto-oncogene expression in human breast cancer cells. J Biol Chem (1988) 1.15
The effect of radiation therapy on lymphocyte subpopulations in cancer patients. Cancer (1976) 1.09
Modulation of 5-fluorouracil metabolism and cytotoxicity by antimetabolite pretreatment in human colorectal adenocarcinoma HCT-8. Cancer Res (1981) 1.07
Role of Rho protein in lovastatin-induced breakdown of actin cytoskeleton. J Pharmacol Exp Ther (1997) 1.04
Efficacy of ursodeoxycholic acid treatment and endoscopic dilation of major duct stenoses in primary sclerosing cholangitis. An 8-year prospective study. J Hepatol (1997) 1.02
Acute ulcer bleeding. A prospective randomized trial to compare Doppler and Forrest classifications in endoscopic diagnosis and therapy. Dig Dis Sci (1997) 1.01
Electrohydraulic lithotripsy treatment of gallstone after disimpaction of the stone from the duodenal bulb (Bouveret's syndrome). Ital J Gastroenterol Hepatol (1999) 1.00
The influence of methotrexate pretreatment on 5-fluorouracil metabolism in L1210 cells. J Biol Chem (1981) 0.97
Prognostic and predictive significance of ErbB-2 breast tumor levels measured by enzyme immunoassay. J Clin Oncol (2001) 0.95
Noninvasive spectroscopic analysis of fluoropyrimidine metabolism in cultured tumor cells. Cancer Res (1986) 0.94
Cancer in married couples: higher or lower distress? J Psychosom Res (1998) 0.93
Enhancement of 5-fluorouracil antitumor effects by the prior administration of methotrexate. Pharmacol Ther (1989) 0.92
Endocrine-responsive pancreatic carcinoma: steroid binding and cytotoxicity studies in human tumor cell lines. Cancer Res (1986) 0.91
Endoscopic biliary stenting for the palliation of pancreatic cancer: results, survival predictive factors, and comparison of 10-French with 11.5-French gauge stents. Am J Gastroenterol (1996) 0.91
Treatment of difficult intrahepatic stones by using extracorporeal and intracorporeal lithotripsy techniques: 10 years' experience in 55 patients. Scand J Gastroenterol (1999) 0.90
An HPLC assay and a microbiological assay to determine levofloxacin in soft tissue, bone, bile and serum. J Pharm Biomed Anal (2001) 0.89
Tamoxifen and 5-fluorouracil in breast cancer: cytotoxic synergism in vitro. Cancer Res (1983) 0.89
Adverse effects of nonsteroidal anti-inflammatory drugs on the small and large bowel. Endoscopy (1999) 0.88
Intravesical chemotherapy in a controlled trial with thio-tepa versus doxorubicin hydrochloride. J Urol (1981) 0.86
Inhibition of growth of leukemic cells by inhibitors of calmodulin: phenothiazines and melittin. Cancer Chemother Pharmacol (1985) 0.85
Optimal schedule of methotrexate and 5-fluorouracil in human breast cancer. Cancer Res (1982) 0.84
Downregulation of ileal bile acid absorption in bile-duct-ligated rats. J Hepatol (2000) 0.84
Endoscopic therapy of adenomas of the papilla of Vater. A retrospective analysis with long-term follow-up. Dig Liver Dis (2000) 0.84
Root substance removal with Er:YAG laser radiation at different parameters using a new delivery system. J Periodontol (2000) 0.84
The significance of the degree of myometrial invasion in patients with stage IB endometrial cancer. Eur J Gynaecol Oncol (2004) 0.84
The role of serum liver enzymes in the diagnosis of choledocholithiasis. Hepatogastroenterology (2001) 0.83
The association of p53 immunopositivity with tumor proliferation and other prognostic indicators in breast cancer. Mod Pathol (1994) 0.83
Relationship of urinary polyamines to tumor activity and tumor volume in patients. Cancer Res (1984) 0.83
Meningiomas after radiotherapy for tinea capitis--still no history. Tumori (1998) 0.83
Treatment of superficial bladder tumors in a controlled trial with thio-TEPA versus adriamycin. J Surg Oncol (1984) 0.83
Molecular lesions involved in the progression of a human breast cancer. Oncogene (1988) 0.82
Clear-cell carcinoma of the kidney. Treatment with a precise technique using cobalt-60. Radiol Clin (Basel) (1975) 0.82
Accelerated schedule of hepatitis B vaccination in liver transplant candidates. Transplant Proc (1998) 0.82
Influence of cholestasis on absorption of ursodeoxycholic acid. Dig Dis Sci (1999) 0.81
Schedule-dependent cytotoxicity of methotrexate and 5-fluorouracil in human colon and breast tumor cell lines. J Clin Invest (1980) 0.80
The reproducibility of histological parameters employed in the novel binary grading systems of endometrial cancer. Eur J Surg Oncol (2008) 0.80
High-quality Si3N4 circuits as a platform for graphene-based nanophotonic devices. Opt Express (2013) 0.80
Further evidence for the use of polyamines as biochemical markers for malignant tumors. Cancer Res (1982) 0.79
Early and late events in the development of human breast cancer. Basic Life Sci (1991) 0.79
First case of isolated small bowel transplantation at the university of cologne: rejection-free course under quadruple immunosuppression and endoluminal monitoring with video-capsule. Transplant Proc (2004) 0.79
Adrenal tumors in BRCA1/BRCA2 mutation carriers. Am J Med Genet (2001) 0.79
Lymphvascular space involvement compromises the survival of patients with stage I endometrial cancer: results of a multicenter study. Eur J Surg Oncol (2007) 0.79
Lower uterine segment involvement is associated with adverse outcome in patients with stage I endometroid endometrial cancer: results of a multicenter study. Eur J Surg Oncol (2008) 0.78
Use of high-dose oral methotrexate sequenced at 24 hours with 5-FU: a clinical toxicity study. Cancer Treat Rep (1983) 0.78
Tamoxifen and 5-fluorouracil in breast cancer: modulation of cellular RNA. Cancer Res (1983) 0.78
[Laparoscopic tumor staging in gastrointestinal carcinomas: significance of internal medicine laparoscopy]. Z Gastroenterol (2001) 0.78
Uridine and cytidine metabolism following inhibition of de novo pyrimidine synthesis by pyrazofurin. Biochim Biophys Acta (1980) 0.78
The outcome of patients with stage I endometrial cancer involving the lower uterine segment. Int J Gynecol Cancer (2007) 0.78
[Various physical parameters of toothbrushing and their relation to the appearance of non-inflammatory gingival recession]. ZWR (1987) 0.78
Temporal pattern of recurrence of stage I endometrial cancer in relation to histological risk factors. Eur J Surg Oncol (2011) 0.77
[Schonlein-Henoch syndrome with severe abdominal involvement in an adult]. Dtsch Med Wochenschr (1996) 0.77
Thymidine enhancement of methotrexate and 5-fluorouracil toxicity in cultured human colon carcinoma. Cancer Chemother Pharmacol (1984) 0.77
Sequential infusions of methotrexate and 5-fluorouracil in advanced cancer: pharmacology, toxicity, and response. Cancer Res (1985) 0.77
[Endoscopic laser lithotripsy for difficult calculi after unsuccessful extracorporeal shock wave lithotripsy]. Arq Gastroenterol (1997) 0.76
Biochemical alterations during unperturbed suspension growth of L1210 cells. Cancer Res (1981) 0.76
[Percutaneous transhepatic cholangioscopy (PTCS)--an important supplement in diagnosis and therapy of biliary tract diseases (indications, technique and results)]. Z Gastroenterol (1995) 0.76
[Severe complications in diagnostic laparoscopy. 9 years experience in 747 examinations]. Med Klin (Munich) (1996) 0.76
Brain effect of intracarotid administration of cisplatinum. Neurol Res (1996) 0.76
Minilaparoscopy versus conventional laparoscopy in the diagnosis of hepatic diseases. Gastrointest Endosc (2001) 0.76
Mechanism of hepatoprotective action of bile salts in liver disease. Gastroenterol Clin North Am (1999) 0.76
Endoscopic stenting in obstructive jaundice due to liver metastases: does it have a benefit for the patient? Hepatogastroenterology (1997) 0.76
[RadioVisioGraphie--system for film-free intraoral radiographs]. Dtsch Zahnarztl Z (1989) 0.75
One-year clinical evaluation of composite fillings and inlays in posterior teeth. Clin Oral Investig (1997) 0.75
Care for dying patients. Lancet (1997) 0.75
Size of metastatic lymph nodes. Case Rep Pathol (2013) 0.75
The founder mutations in the BRCA1, BRCA2, and ATM genes in Moroccan Jewish women with breast cancer. Genet Test (2000) 0.75
Intravesical chemotherapy of superficial bladder tumors in a controlled trial with cis-platinum versus cis-platinum plus hyaluronidase. J Surg Oncol (1985) 0.75
Typhoid fever due to Salmonella Kapemba infection in an otherwise healthy middle-aged man. J Clin Microbiol (1999) 0.75
Lactic dehydrogenase isozymes, 31P magnetic resonance spectroscopy, and in vitro antimitochondrial tumor toxicity with gossypol and rhodamine-123. J Clin Invest (1987) 0.75
Separation of tamoxifen geometric isomers and metabolites by bonded-phase beta-cyclodextrin chromatography. J Chromatogr (1987) 0.75
Flow cytometric analysis of fluorescein-conjugated estradiol (E-BSA-FITC) binding in breast cancer suspensions. Cytometry (1985) 0.75
Effects of cis- and trans-tamoxifen isomers on RNA incorporation of human breast cancer cells. Mol Pharmacol (1987) 0.75
[Effectiveness of a 5% KNO3 toothpaste on dentin hypersensitivity]. Dtsch Zahnarztl Z (1987) 0.75
[Aspects of quality in intra- and extraoral radiographs]. Zahnarztl Mitt (1987) 0.75
[Elderly cancer patients requiring skilled nursing care]. Harefuah (1996) 0.75
Cytotoxicity of several chemotherapeutic agents in a human pancreatic cancer cell line (Colo-357). Cancer Treat Rep (1984) 0.75
[Effects of the high-frequency current used in electrosurgery on hard tooth substance and pulp]. Dtsch Zahnarztl Z (1987) 0.75
Effect of de novo purine synthesis inhibitors on 5-fluorouracil metabolism and cytotoxicity. Biochem Pharmacol (1981) 0.75
Chemoendocrine therapy with prolonged estrogen priming in advanced breast cancer: endocrine pharmacokinetics and toxicity. Cancer Treat Rep (1987) 0.75
[Intensity differences of new and used daylight devices for synthetic resin fillings technics]. Quintessenz (1987) 0.75